MTOR and prostate cancer: Overall, light irradiation of prostate cancer cells is shown in the present investigation to profoundly elevate curcumin’s bioavailability, with a concentration of 0.2 μg/mL distinctly blocking tumor proliferation by interacting with the CDK-cyclin axis and the Akt-mTOR pathway.